|
|
|
|
|
|
x
|
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
|
|
|
For the quarterly period ended September 30, 2013.
|
|
|
|
or
|
|
|
¨
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT.
|
|
|
For the transition period from _________________to ________________
|
Nevada
|
|
84-0922701
|
(State or other jurisdiction of
|
|
(I.R.S. Employer
|
incorporation or organization)
|
|
Identification Number)
|
|
225 N.E. Mizner Boulevard, Suite 400 Boca Raton, Florida 33432
|
|
|
(Address of Principal Executive Office) (Zip Code)
|
|
|
(561) 362-5385
|
|
|
(Registrant’s telephone number including area code)
|
|
Large accelerated filer
|
¨
|
|
Accelerated filer
|
¨
|
|
|
|
|
|
Non-accelerated filer
|
¨
|
|
Smaller reporting company
|
x
|
|
|
Page
|
|
|
|
PART I
|
FINANCIAL INFORMATION
|
3
|
|
|
|
Item 1.
|
Financial Statements
|
3
|
|
|
|
|
Consolidated Balance Sheets as of September 30, 2013 (unaudited) and December 31, 2012
|
3
|
|
|
|
|
Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2013 and 2012 (unaudited)
|
4
|
|
|
|
|
Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2013 and 2012(unaudited)
|
5
|
|
|
|
|
Notes to Condensed Consolidated Financial Statements
|
6
|
|
|
|
Item 2.
|
Management Discussion and Analysis of Financial Condition and Results of Operations
|
8
|
|
|
|
Item 4.
|
Controls and Procedures
|
10
|
|
|
|
PART II
|
OTHER INFORMATION
|
11
|
|
|
|
Item 1.
|
Legal Proceedings
|
11
|
|
|
|
Item 6.
|
Exhibits
|
12
|
|
|
|
SIGNATURES
|
14
|
2 | ||
|
3 | ||
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
||||||||
|
|
September 30,
|
|
September 30,
|
|
||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative expenses
|
|
$
|
6,829
|
|
$
|
2,966
|
|
$
|
14,832
|
|
$
|
17,825
|
|
TOTAL EXPENSES
|
|
|
6,829
|
|
|
2,966
|
|
|
14,832
|
|
|
17,825
|
|
OTHER INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Income
|
|
|
|
|
|
42
|
|
|
7
|
|
|
104
|
|
TOTAL OTHER INCOME
|
|
|
|
|
|
42
|
|
|
7
|
|
|
104
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET LOSS BEFORE TAXES
|
|
|
(6,829)
|
|
|
(2,924)
|
|
|
(14,825)
|
|
|
(17,721)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET LOSS
|
|
$
|
(6,829)
|
|
$
|
(2,924)
|
|
$
|
(14,825)
|
|
$
|
(17,721)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET LOSS PER COMMON SHARE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and Dilutive
|
|
$
|
(.01)
|
|
$
|
(.00)
|
|
$
|
(.01)
|
|
$
|
(.01)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WEIGHTED AVERAGE NUMBER OF COMMON
SHARES OUTSTANDING |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and Dilutive
|
|
|
1,260,773
|
|
|
1,260,773
|
|
|
1,260,773
|
|
|
1,260,773
|
|
4 | ||
|
|
|
Nine Months Ended
|
|
||||
|
|
September 30,
|
|
September 30,
|
|
||
|
|
2013
|
|
2012
|
|
||
|
|
|
|
|
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(14,825)
|
|
$
|
(17,721)
|
|
Adjustment to reconcile net loss to net cash used in operating activities
|
|
|
|
|
|
|
|
Changes in assets and liabilities
|
|
|
|
|
|
|
|
Decrease in prepaid tax
|
|
|
|
|
|
12,674
|
|
Decrease in accounts payable and accrued expenses
|
|
|
(13,927)
|
|
|
(13,200)
|
|
|
|
|
|
|
|
|
|
Net Cash Used in Operating Activities
|
|
|
(28,752)
|
|
|
(18,247)
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from related party note
|
|
|
7,200
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
7,200
|
|
|
|
|
|
|
|
|
|
|
|
|
NET DECREASE IN CASH AND CASH EQUIVALENTS
|
|
|
(21,552)
|
|
|
(18,247)
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIODS
|
|
|
22,357
|
|
|
44,340
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS, END OF PERIODS
|
|
$
|
805
|
|
$
|
26,093
|
|
5 | ||
|
6 | ||
|
7 | ||
|
8 | ||
|
9 | ||
|
10 | ||
|
11 | ||
|
3.1
|
Articles of Incorporation for Ridgefield Acquisition Corp., a Colorado corporation, incorporated by reference to Registration Statement No. 33-13074-D as Exhibit 3.1.
|
|
|
3.2
|
Amended Bylaws adopted June 1, 1987, for Ridgefield Acquisition Corp., a Colorado corporation, incorporated by reference to Annual Report on Form 10-K for the fiscal year ended December 31, 1987 as Exhibit 3.2.
|
|
|
3.4
|
Articles of Amendment to Restated Articles of Incorporation, dated March 7, 1991, for Ridgefield Acquisition Corp., a Colorado corporation, incorporated by reference to Annual Report on Form 10-K for fiscal year ended December 31, 1990 as Exhibit 3.4.
|
|
|
3.5
|
Articles of Amendment to Restated Articles of Incorporation for Ridgefield Acquisition Co., a Colorado Corporation, dated March 17, 1999, incorporated by reference to the Company’s Current Report on Form 8-K reporting an event of March 9, 1999.
|
|
|
3.6
|
Articles of Incorporation of Bio-Medical Automation, Inc., a Nevada corporation, Ridgefield Acquisition Corp.’s wholly owned subsidiary, incorporated by reference to the Company’s Current Report on Form 8-K reporting an event of March 7, 2003.
|
|
|
3.7
|
By-laws of Bio-Medical Automation, Inc. a Nevada corporation, the Company’s wholly owned subsidiary, incorporated by reference to the Annual Report on form 10-KSB for the year ended December 31, 2005 as exhibit 3.7.
|
|
|
3.8
|
Articles of Incorporation for Ridgefield Acquisition Corp., a Nevada corporation, incorporated by reference to Appendix C of the Proxy Statement, dated, May 26, 2006.
|
|
|
3.9
|
Bylaws for Ridgefield Acquisition Corp., a Nevada corporation, incorporated by reference to Appendix D of the Proxy Statement, dated May 26, 2006.
|
|
|
10.1
|
OEM Purchase Agreement dated January 15, 1990, between Ridgefield Acquisition Corp. and Ariel Electronics, Inc. incorporated by reference to Annual Report on Form 10-K for the fiscal year ended December 31, 1989 as Exhibit 10.1.
|
|
|
10.2
|
Form of Convertible Promissory Note, 12/30/93 Private Placement, incorporated by reference to Annual Report on Form 10-KSB for the fiscal year ended December 31, 1993 as Exhibit 10.2.
|
|
|
10.3
|
Form of Non-Convertible Promissory Note, 12/30/93 Private Placement incorporated by reference to Annual Report on Form 10-KSB for the fiscal year ended December 31, 1993 as Exhibit 10.3.
|
|
|
10.4
|
Form of Note Purchaser Warrant Agreement and Warrant, 12/30/93 Private Placement incorporated by reference to Annual Report on Form 10-KSB for the fiscal year ended December 31, 1993 as Exhibit 10.4.
|
|
|
10.5
|
Form of Promissory Note, April 1, 1996, incorporated by reference to Annual Report on Form 10-KSB for the fiscal year ended December 31, 1996 as Exhibit 10.5.
|
12 | ||
|
10.6
|
Form of Security Agreement, April 1, 1996, incorporated by reference to Annual Report on Form 10-KSB for the fiscal year ended December 31, 1996 as Exhibit 10.6.
|
|
|
10.7
|
Form of Common Stock Purchase Warrant, April 1, 1996, incorporated by reference to Annual Report on Form 10-KSB for the fiscal year ended December 31, 1996 as Exhibit 10.7.
|
|
|
10.8
|
Form of Promissory Note, July 1, 1996, incorporated by reference to Annual Report on Form 10-KSB for the fiscal year ended December 31, 1996 as Exhibit 10.8.
|
|
|
10.9
|
Form of April 1, 1996 Promissory Note Extension, October 17, 1996, incorporated by reference to Annual Report on Form 10-KSB for the fiscal year ended December 31, 1996 as Exhibit 10.9.
|
|
|
10.10
|
Form of Common Stock Purchase Warrant, October 10, 1996, incorporated by reference to Annual Report on Form 10-KSB for the fiscal year ended December 31, 1996 as Exhibit 10.10.
|
|
|
10.11
|
Asset Purchase Agreement with JOT, incorporated by reference to Form 8-K reporting an event of November 4, 1998, and amendment thereto incorporated by reference to Form 8-K reporting an event of December 15, 1998 as Exhibit 10.11.
|
|
|
10.12
|
Stock Purchase Agreement, between Bio-Medical Automation, Inc. and Steven N. Bronson, incorporated by reference to the Current Report on Form 8-K filed on April 6, 2000 as Exhibit 10.12.
|
|
|
10.13
|
Employment Agreement between Bio-Medical Automation, Inc. and Steven N. Bronson, dated as of March 24, 2001, incorporated by reference to Quarterly Report on Form 10-QSB for the quarter ended March 31, 2001 as Exhibit 10.13.
|
|
|
10.14
|
Mergers and Acquisitions Advisory Agreement, dated as of November 13, 2001, between Bio-Medical Automation, Inc. and Catalyst Financial LLC incorporated by reference to the Annual Report on Form 10-KSB for the year ended December 31, 2001 as Exhibit 10.14.
|
|
|
10.15
|
Mergers and Acquisitions Advisory Agreement, dated as of April 1, 2005, between Ridgefield Acquisition Corp. and Catalyst Financial LLC. Incorporated by reference to Quarterly Report on Form 10-QSB for the quarter ended June 30, 2005 as Exhibit 10.15.
|
|
|
10.16
|
Appointment of Atlas Stock Transfer Agent Corporation as the transfer Agent for Ridgefield Acquisition Corp. incorporated by reference to the Annual Report on Form 10-KSB for the year ended December 31, 2005 as Exhibit 10.16.
|
|
|
10.17
|
Employment Agreement between Ridgefield Acquisition Corp. and Steven N. Bronson, dated as of March 28, 2006. incorporated by reference to the Annual Report on Form 10-KSB for the year ended December 31, 2005 as Exhibit 10.17.
|
|
|
10.18
|
Addendum, dated as of February 1, 2006, to Mergers and Acquisitions Advisory Agreement, dated as of April 1, 2005, between Ridgefield Acquisition Corp. and Catalyst Financial LLC. incorporated by reference to the Annual Report on Form 10-KSB for the year ended December 31, 2005 as Exhibit 10.18.
|
|
|
10.19*
|
Loan Agreement between Steven N. Bronson and Ridgefield Acquisition Corp., dated November 12, 2013 attached hereto as Exhibit 10.19.
|
13 | ||
|
14
|
Code of Ethics incorporated by reference to the Annual Report on Form 10-KSB for the year ended December 31, 2003 as Exhibit 10.14.
|
|
|
31*
|
President’s Written Certification Of Financial Statements Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32*
|
President’s Written Certification Of Financial Statements Pursuant to 18 U.S.C. Statute 1350.
|
101.INS*#
|
XBRL Instance Document
|
101.SCH*#
|
XBRL Taxonomy Extension Schema
|
101.CAL*#
|
XBRL Taxonomy Extension Calculation Linkbase
|
101.DEF*#
|
XBRL Taxonomy Extension Definition Linkbase
|
101.LAB*#
|
XBRL Taxonomy Extension Label Linkbase
|
101.PRE*#
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
|
RIDGEFIELD ACQUSITION CORP.
|
|
|
|
|
By:
|
/s/ Steven N. Bronson
|
|
|
Steven N. Bronson, President
|
|
|
(Principle Executive Officer),
|
|
|
as Registrant’s duly authorized officer
|
14 | ||
|
|
|
|
Number
|
|
Description of Document
|
|
|
|
10.19*
|
|
Loan Agreement between Steven N. Bronson and Ridgefield Acquisition Corp., dated November 12, 2013.
|
|
|
|
31*
|
|
President’s Written Certification Of Financial Statements Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
32*
|
|
President’s Written Certification Of Financial Statements Pursuant to 18 U.S.C. Statute 1350.
|
|
|
|
101.INS*#
|
|
XBRL Instance Document
|
101.SCH*#
|
|
XBRL Taxonomy Extension Schema
|
101.CAL*#
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
101.DEF*#
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
101.PRE*#
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
15 | ||
|
Exhibit 10.19
LOAN AGREEMENT
This Loan Agreement (the “Agreement”), dated November 12, 2013, is entered into by and between Ridgefield Acquisition Corp., a Nevada corporation, with offices located at 225 N.E. Mizner Boulevard, Suite 400 Boca Raton, Florida 33432 (“Borrower”) and Steven N. Bronson, having a business address at 225 N.E. Mizner Boulevard, Suite 400 Boca Raton, Florida 33432 (the “Lender”).
WHEREAS , the Lender has loaned and advanced the Borrower monies (each a “Principal Advance” and collectively the “Principal Advances”) in the aggregate amount of $7,200.00 (the “Loan”), as follows:
1. | $1,200.00 on August 5, 2013; |
2. | $5,000.00 on August 23, 2013; and |
3. | $1,000.00 on September 20, 2013. |
WHEREAS , each of the Principal Advances accrues interest at the rate of ten percent (10%) per year from the date of the Principal Advance.
WHEREAS , the parties hereto desire to memorialize the Loan and mutually agree that the Loan shall be shall be subject to the following terms and conditions.
NOW, THEREFORE , in consideration of the mutual promises set forth herein, the parties hereto agree as follows:
1. Principal. The principal amount of the Loan is $7,200.00. The principal amount and all accrued interest on the Loan is due and payable within ten (10) business days following Borrower’s receipt of a written demand for payment from Payee or immediately upon the occurrence of an Event of Default, as defined herein (the “Maturity Date”). The obligations of the Borrower to make payments provided for in this Agreement are absolute and unconditional and not subject to any defense, set-off, counterclaim, rescission, recoupment or adjustment whatsoever. Upon payment in full of all principal and interest payable hereunder, this Agreement shall be surrendered to the Borrower for cancellation.
2. Interest. The Loan shall bear interest on the outstanding principal amount from the date of each Principal Advance until such amounts are repaid to Lender in full, at the rate of 10% per annum . In the event any payment due hereunder shall not be paid on the Maturity Date, then the outstanding principal amount shall bear interest at the lesser of 15% per annum or the highest lawful rate permitted under applicable law, from the date when such payment was due until paid. Additionally, B orrower’s failure to tender a payment, or any part thereof, in accordance with this Agreement above shall constitute an Event of Default. If an Event of Default shall occur due to the Borrower’s failure to make a payment on the required date, Payee shall have no obligation to serve a notice of default. In the event the Borrower fails to remedy the default within five (5) business days after the Event of Default (the “Default Date”), then all outstanding principal and accrued interest shall automatically accelerate and become immediately due and owing (the “Accelerated Debt”). The Accelerated Debt shall accrue interest at the rate of 15% per annum from the Default Date until the Accelerated Debt is paid in full. Payee shall have no obligation to provide notice to Borrower concerning the Default Date, the acceleration of the debt or the interest rate on the Accelerated Debt.
1 |
This paragraph shall not be deemed to extend or otherwise modify or amend the date when such payments are due hereunder. The obligations of the Borrower under this Agreement are subject to the limitation that payments of interest shall not be required to the extent that the charging of or the receipt of any such payment by the holder of this Agreement would be contrary to the provisions of law applicable to the holder of this Agreement limiting the maximum rate of interest which may be charged or collected by the holder of this Agreement . In no event shall any interest to be paid hereunder exceed the maximum rate permitted by law. In any such event, this Agreement shall automatically be deemed amended to permit interest charges at an amount equal to, but no greater than, the maximum rate permitted by law.
3. Representations and Warranties . The Borrower represents and warrants as follows:
(a) The Borrower has all requisite power and authority to enter into this Agreement and to consummate the transactions contemplated hereby. This Agreement has been duly executed and delivered by the Borrower and constitutes a valid and binding obligation of the Borrower, enforceable in accordance with its terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally and (b) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies.
(b) This Agreement is the legal, valid and binding obligation of the Borrower, enforceable in accordance with its terms, except as limited by applicable bankruptcy, insolvency, and other similar laws affecting creditors’ rights generally.
4. Events of Default.
The principal amount and all accrued interest on this Loan is due and payable upon the Maturity Date, as defined above. Additionally, the principal amount and all accrued interest on this Loan shall automatically become immediately due and payable upon the occurrence of any of the following events, each of which shall be deemed an “Event of Default”:
(a) When there is any misstatement or false statement in connection with, noncompliance with or nonperformance of any of the Borrower’s obligations, representation, warranties or covenants under or emanating from this Agreement;
(b) If the Borrower shall make an assignment for the benefit of creditors or shall admit in writing his inability to pay his debts as they become due or if the Borrower shall file a voluntary petition in bankruptcy, or shall be adjudicated a bankrupt or insolvent, or shall file any petition or answer seeking any reorganization arrangement, composition, readjustment, liquidation, dissolution, or similar relief under the present or any future federal bankruptcy code or other applicable federal, state or similar statute, law or regulation, or shall seek or consent to or acquiesce in the appointment of any trustee, receiver or liquidator of the Borrower or of all or any substantial part of its properties.
5. Notices . Any notice, other communication or payment required or permitted hereunder shall be in writing and shall be delivered personally or sent by FedEx mail or similar overnight delivery, postage prepaid to the parties at the addresses set forth above. Each of the above addressees may change its address for purposes of this paragraph by giving to the other addressee notice of such new address in conformance with this paragraph.
6. Waivers . The Borrower hereby waives presentment, demand for performance, notice of non-performance, protest, notice of protest and notice of dishonor. No delay on the part of Lender in exercising any right hereunder shall operate as a waiver of such right or any other right. This Agreement is being delivered in and shall be construed in accordance with the laws of the State of Florida, without regard to the conflicts of laws provisions thereof.
2 |
7. Attorneys’ Fees . If the indebtedness represented by this Agreement or any part thereof is collected in bankruptcy, receivership or other judicial proceedings or if this Loan is placed in the hands of attorneys for collection after default, the Borrower agrees to pay, in addition to the principal payable hereunder, the reasonable attorneys’ fees and collection costs incurred by Lender in attempting to collect the Loan.
8. No Changes . This Agreement may not be changed or terminated orally, but only by an agreement in writing signed by the party against whom enforcement of any change, modification, termination, waiver, or discharge is sought.
IN WITNESS WHEREOF , the parties hereto have executed this Agreement as of the date first above written.
BORROWER – Ridgefield Acquisition Corp.
/s/ Leonard Hagan
__________________________
Leonard Hagan, Director
LENDER – Steven N. Bronson
/s/ Steven N. Bronson
_____________________________
Steven N. Bronson
3 |
Exhibit 31
Statement Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
By Principal Executive Officer and Principal Financial Officer
Regarding Facts and Circumstances Relating to Exchange Act Filings
I, Steven N. Bronson, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2013 of Ridgefield Acquisition Corp.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business
issuer as of, and for, the periods presented in this report;
4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the small business issuer and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c. Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d. Disclosed in this report any change in the small business issuer's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and
5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the small business issuer's auditors and the audit committee of the small business issuer's board of directors (or persons performing the equivalent functions):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting.
Dated: November 13, 2013
/s/ Steven N. Bronson
Steven N. Bronson,
Principle Executive Officer
Exhibit 32
President's Written Certification
Of Financial Statements
Pursuant to 18 U.S.C. Statute 1350
Pursuant to 18 U.S.C. Statute 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies in his capacity as president of Ridgefield Acquisition Corp. (the "Company") that
(a) | the Quarterly Report of the Company on Form 10-Q for the period Ended September 30, 2013 fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, and |
(b) | the information contained in such report fairly presents, in all material respects, the financial condition of the Company at the end of such period and the results of operations of the Company for such |
period.
Dated: November 13, 2013
/s/ Steven N. Bronson
Steven N. Bronson,
Principle Executive Officer